Robert Bindert Huizinga - Net Worth and Insider Trading

Robert Bindert Huizinga Net Worth

The estimated net worth of Robert Bindert Huizinga is at least $567,520 dollars as of 2024-11-13. Robert Bindert Huizinga is the EVP of Research of Aurinia Pharmaceuticals Inc and owns about 69,379 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $567,520. Details can be seen in Robert Bindert Huizinga's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Bindert Huizinga has not made any transactions after 2022-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Bindert Huizinga

To

Robert Bindert Huizinga Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Bindert Huizinga owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .

Click here to see the complete history of Robert Bindert Huizinga’s form 4 insider trades.

Insider Ownership Summary of Robert Bindert Huizinga

Ticker Comapny Transaction Date Type of Owner
AUPH Aurinia Pharmaceuticals Inc 2022-03-02 Ex Vice President of Research

Robert Bindert Huizinga Latest Holdings Summary

Robert Bindert Huizinga currently owns a total of 1 stock. Robert Bindert Huizinga owns 69,379 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 2, 2022, with a value of $567,520.

Latest Holdings of Robert Bindert Huizinga

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AUPH Aurinia Pharmaceuticals Inc 2022-03-02 69,379 8.18 567,520

Holding Weightings of Robert Bindert Huizinga


Robert Bindert Huizinga Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Bindert Huizinga has made a total of 5 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 4,849 shares on March 2, 2022, which brought Robert Bindert Huizinga around $58,237.

Insider Trading History of Robert Bindert Huizinga

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Bindert Huizinga Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Bindert Huizinga Ownership Network

Ownership Network List of Robert Bindert Huizinga

No Data

Ownership Network Relation of Robert Bindert Huizinga

Insider Network Chart

Robert Bindert Huizinga Owned Company Details

What does Aurinia Pharmaceuticals Inc do?

Who are the key executives at Aurinia Pharmaceuticals Inc?

Robert Bindert Huizinga is the Ex Vice President of Research of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .

Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary

Over the past 18 months, Robert Bindert Huizinga made no insider transaction in Aurinia Pharmaceuticals Inc (AUPH). Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 13,679 shares made by Jayne David R.w. .

In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 9,798 shares. During the past 18 months, 397,215 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,215 shares.

Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aurinia Pharmaceuticals Inc Insider Transactions

No Available Data

Robert Bindert Huizinga Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Bindert Huizinga. You might contact Robert Bindert Huizinga via mailing address: #1203-4464 Markham Street, Victoria A1 Bc V8z7x8.